Khaled Abduljalil - Concepedia

Author

Khaled Abduljalil

Simcyp (United Kingdom)ORCID

Also Known As

K Abduljalil, K. Abdul-Jalil, K. Abduljalil, Khaled Abduljalil

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Simcyp (United Kingdom)University of Manchester University of Cologne University Hospital Cologne

About

Khaled Abduljalil is an author at Simcyp (United Kingdom) specializing in pharmacokinetic modeling, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1K
2	Public Health	4	4	398
3	Biochemistry	3	3	228
4	Health Sciences	2	2	108
5	Biostatistics	1	1	21

Khaled Abduljalil

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy Khaled Abduljalil, Penny Furness, Trevor N. Johnson, Clinical Pharmacokinetics Normal PregnancyMetabolic ChangesPhysiologyGynecologyMaternal Health	2012	347
Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations Khaled Abduljalil, Theresa Cain, Helen Humphries, Drug Metabolism and Disposition	2014	143
A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data Farzaneh Salem, Trevor N. Johnson, Khaled Abduljalil, Clinical Pharmacokinetics Genetic AnalysisVivo DataBiochemistryMitochondrial FunctionGenetics	2014	123
A pregnancy physiologically based pharmacokinetic (p‐<scp>PBPK</scp>) model for disposition of drugs metabolized by <scp>CYP1A2</scp>, <scp>CYP2D6</scp> and <scp>CYP3A4</scp> Lu Gaohua, Khaled Abduljalil, Masoud Jamei, British Journal of Clinical Pharmacology	2012	119
Changes in Individual Drug-Independent System Parameters during Virtual Paediatric Pharmacokinetic Trials: Introducing Time-Varying Physiology into a Paediatric PBPK Model Khaled Abduljalil, Masoud Jamei, Amin Rostami‐Hodjegan, The AAPS Journal Time-varying PhysiologyPharmacokinetic ModelingMedicinePediatricsPharmacotherapy	2014	87
Factors Influencing Pharmacokinetics of Prophylactic Posaconazole in Patients Undergoing Allogeneic Stem Cell Transplantation V. Kohl, Carsten Müller, Oliver A. Cornely, Antimicrobial Agents and Chemotherapy Prophylactic PosaconazoleTransplantation MedicineTdm ResultsSct RecipientsPharmacotherapy	2009	77
Application of a Physiologically Based Pharmacokinetic Model to Predict <i>OATP1B1</i>‐Related Variability in Pharmacodynamics of Rosuvastatin RH Rose, Sibylle Neuhoff, Khaled Abduljalil, CPT Pharmacometrics & Systems Pharmacology Pd ResponsePharmacotherapyPhysiologically-based Pharmacokinetic ModelingPharmacodynamic ModelingMolecular Pharmacology	2014	74
Assessment of Activity Levels for CYP2D61, CYP2D62, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan Khaled Abduljalil, Dorothee Frank, Andrea Gaedigk, Clinical Pharmacology & Therapeutics	2010	60
Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability Manoranjenni Chetty, Rachel H. Rose, Khaled Abduljalil, Frontiers in Pharmacology	2014	58
Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy Khaled Abduljalil, Amita Pansari, Masoud Jamei Journal of Pharmacokinetics and Pharmacodynamics Pharmacokinetic ModelsPharmacokinetic ModelingLongitudinal ChangesMedicinePhysiology	2020	56

Page 1